Muta Tsuyoshi, Sawada Yuichiro, Moriyama Yasunori, Seike Yasuko, Tokuyama Takahito, Ueda Yoko, Fujisaki Tomoaki
Department of Internal Medicine, Matsuyama Red-Cross Hospital, Japan.
Rinsho Ketsueki. 2010 Dec;51(12):1769-74.
We report a case of a 46-year-old female demonstrating general fatigue and visual disturbances with retinal bleeding. She had a white blood cell count of 419,300/mm. Thereafter, she developed vomiting associated with vertigo caused by cerebellar hemorrhage, deteriorating to acute hydrocephalus secondary to obstruction of the cerebral aqueduct. Emergency procedures for cerebral protection, such as hyperventilation, administration of mannitol, and barbiturate coma, were performed. Bone marrow examination showed a positive BCR-ABL/t(9;22)(q34;q11) chromosomal translocation detected by FISH and RT-PCR (masked Ph) and she was diagnosed as having chronic myeloid leukemia (CML) in the chronic phase (CP). She was administered Ara-C, together with imatinib 600 mg/d through a nasogastric tube. Eight days later, she underwent successful extubation and recovered without any neurological defect. She was maintained on imatinib 400 mg/d and demonstrated a major molecular response at 15 months. Physicians need to be aware that brain hemorrhage may develop as an initial symptom of CML patients in CP.
我们报告一例46岁女性病例,该患者表现出全身乏力及伴有视网膜出血的视觉障碍。她的白细胞计数为419,300/mm。此后,她出现了与小脑出血所致眩晕相关的呕吐症状,并恶化为继发于中脑导水管梗阻的急性脑积水。实施了诸如过度换气、给予甘露醇和巴比妥类昏迷等脑保护的急救措施。骨髓检查显示,通过荧光原位杂交(FISH)和逆转录聚合酶链反应(RT-PCR)检测到BCR-ABL/t(9;22)(q34;q11)染色体易位阳性(隐匿性Ph),她被诊断为慢性期(CP)慢性髓性白血病(CML)。通过鼻饲管给予她阿糖胞苷以及每天600毫克的伊马替尼。八天后,她成功拔管,且未遗留任何神经功能缺损而康复。她继续维持每天400毫克伊马替尼的治疗,并在15个月时表现出主要分子反应。医生需要意识到脑出血可能作为CP期CML患者的首发症状出现。